ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 48 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,488,000 | -45.0% | 217,328 | 0.0% | 0.02% | -40.5% |
| Q1 2017 | $4,520,000 | 0.0% | 217,328 | 0.0% | 0.04% | -15.9% |
| Q4 2016 | $4,520,000 | -36.5% | 217,328 | 0.0% | 0.04% | -32.3% |
| Q3 2016 | $7,122,000 | +31.2% | 217,328 | 0.0% | 0.06% | +14.0% |
| Q2 2016 | $5,427,000 | -67.7% | 217,328 | -57.7% | 0.06% | -63.2% |
| Q3 2015 | $16,820,000 | -64.4% | 513,439 | -42.4% | 0.16% | -62.6% |
| Q2 2015 | $47,233,000 | +86.1% | 891,688 | +1.4% | 0.41% | +96.2% |
| Q1 2015 | $25,385,000 | +469.0% | 879,581 | +473.6% | 0.21% | +358.7% |
| Q4 2014 | $4,461,000 | +129.5% | 153,350 | 0.0% | 0.05% | +91.7% |
| Q3 2014 | $1,944,000 | -36.8% | 153,350 | 0.0% | 0.02% | -36.8% |
| Q2 2014 | $3,078,000 | – | 153,350 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 6,402,366 | $128,496,000 | 6.43% |
| Cormorant Asset Management, LP | 150,000 | $3,011,000 | 0.80% |
| PFM Health Sciences, LP | 738,027 | $14,812,000 | 0.30% |
| Partner Investment Management, L.P. | 27,893 | $560,000 | 0.11% |
| Spark Investment Management LLC | 32,100 | $642,000 | 0.10% |
| PointState Capital LP | 275,000 | $5,519,000 | 0.07% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 97,809 | $1,963,000 | 0.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 100,000 | $2,007,000 | 0.06% |
| Nicholas Investment Partners, LP | 50,456 | $1,013,000 | 0.06% |
| Baker Brothers Advisors | 153,350 | $3,078,000 | 0.04% |